CXCL10 and acute respiratory distress syndrome: We also assessed the chemokine CXCL10 (C-X-C motif chemokine ligand 10), which has been identified as robust biomarker for COVID-19 outcome with elevated levels linked to acute respiratory stress syndrome (ARDS) and neurological complications.44